We are live on ! Find out more
GSK icon

GSK
GSK

846 hedge funds and large institutions have $10.4B invested in GSK in 2023 Q3 according to their latest regulatory filings, with 99 funds opening new positions, 305 increasing their positions, 268 reducing their positions, and 69 closing their positions.

New
Increased
Maintained
Reduced
Closed

226% more call options, than puts

Call options by funds: $414M | Put options by funds: $127M

43% more first-time investments, than exits

New positions opened: 99 | Existing positions closed: 69

14% more repeat investments, than reductions

Existing positions increased: 305 | Existing positions reduced: 268

9% more funds holding in top 10

Funds holding in top 10: 11 → 12 (+1)

2% more funds holding

Funds holding: 827 → 846 (+19)

5% more capital invested

Capital invested by funds: $9.91B → $10.4B (+$453M)

0.19% more ownership

Funds ownership: 6.79% → 6.98% (+0.19%)

Holders
846
Holders Change
+19
Holders Change %
+2.3%
% of All Funds
13.43%
Holding in Top 10
12
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+9.09%
% of All Funds
0.19%
New
99
Increased
305
Reduced
268
Closed
69
Calls
$414M
Puts
$127M
Net Calls
+$287M
Net Calls Change
+$213M

Top Buyers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
+$157M
2
Holocene Advisors
Holocene Advisors
New York
+$74.4M
3
Millennium Management
Millennium Management
New York
+$53.6M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$45.8M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$44.2M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$127M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$102M
3
JEST
JTC Employer Solutions Trustee
Jersey
-$45.7M
4
Nomura Holdings
Nomura Holdings
Japan
-$45.4M
5
CCM
Camber Capital Management
Massachusetts
-$44.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Legacy Financial Group (Iowa)
826
Legacy Financial Group (Iowa)
Iowa
$2.11K +$2.06K +58 New
BAM
827
Byrne Asset Management
New Jersey
$2K – – –
DWMG
828
DB Wealth Management Group
California
$1.7K +$1.67K +47 New
RG
829
Retirement Group
California
$1.45K – – –
RL
830
Rogco LP
Oklahoma
$1.45K +$1.42K +40 New
TFM
831
TFC Financial Management
Massachusetts
$1.45K +$1.42K +40 New
AWM
832
Abound Wealth Management
Tennessee
$1.38K – – –
GWMIA
833
Global Wealth Management Investment Advisory
Florida
$1.38K – – –
LFA
834
LGT Financial Advisors
Texas
$1.3K +$1.28K +36 New
GJIA
835
Glass Jacobson Investment Advisors
Maryland
$1.16K – – –
BCM
836
Bourgeon Capital Management
Connecticut
$1.12K +$1.1K +31 New
WIM
837
Westside Investment Management
California
$1.01K – – –
TFA
838
Transamerica Financial Advisors
Florida
$1K – – –
CAL
839
Capital Analysts LLC
Pennsylvania
$1K +$852 +24 New
CCP
840
Carmel Capital Partners
California
$928 +$106 +3 +13%
VCM
841
Versant Capital Management
Arizona
$870 – – –
Zurich Cantonal Bank
842
Zurich Cantonal Bank
Switzerland
$870 – – –
HWP
843
Highline Wealth Partners
California
$725 +$710 +20 New
DWA
844
Delos Wealth Advisors
Texas
$598 – – –
CPG
845
Cornerstone Planning Group
New Jersey
$326 +$319 +9 New
APC
846
Aspire Private Capital
North Carolina
$253 – – –
WWM
847
Wolff Wiese Magana
California
$145 -$1.14K -32 -89%
BC
848
Brookfield Corp
Ontario, Canada
– -$23M -644,249 Closed
IHAM
849
Integral Health Asset Management
New York
– -$12.5M -350,000 Closed
Norges Bank
850
Norges Bank
Norway
– -$6.77M -189,999 Closed
32 33
34
35 36

GSK Hedge Fund Activity: Q3 2023 in Review

846 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in GSK (GSK) for Q3 2023, worth a combined $10.4B — up 4.6% from $9.91B a quarter earlier.

Buyers outnumbered sellers: 99 funds opened new GSK positions and 69 closed out — a net gain of 30 holders — while 305 added to existing stakes and 268 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $157M. The largest seller was Goldman Sachs, cutting an estimated $127M.

  • 846 institutional investors held GSK (GSK) as of Q3 2023, up from 827 in Q2 2023.
  • Funds reported $10.4B of GSK stock for Q3 2023, up 4.6% quarter-over-quarter.
  • 99 funds opened new GSK positions in Q3 2023 and 69 closed out, a net change of +30 holders.
  • The largest GSK buyer in Q3 2023 was Deutsche Bank, an estimated $157M added.
  • The largest GSK seller in Q3 2023 was Goldman Sachs, an estimated $127M sold.

Based on aggregated 13F filings for Q3 2023.